These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 19546541

  • 1. Endogenous activated protein C predicts hemorrhagic transformation and mortality after tissue plasminogen activator treatment in stroke patients.
    Mendioroz M, Fernández-Cadenas I, Alvarez-Sabín J, Rosell A, Quiroga D, Cuadrado E, Delgado P, Rubiera M, Ribó M, Molina C, Montaner J.
    Cerebrovasc Dis; 2009; 28(2):143-50. PubMed ID: 19546541
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
    Kimura K, Iguchi Y, Shibazaki K, Kobayashi K, Uemura J, Aoki J, Yamashita S, Terasawa Y, Matsumoto N.
    J Neurol Sci; 2008 Jul 15; 270(1-2):48-52. PubMed ID: 18304581
    [Abstract] [Full Text] [Related]

  • 6. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T, Suarez JI, Tarr RW, Welter E, Landis D, Sunshine JL, Zaidat OO.
    J Stroke Cerebrovasc Dis; 2008 Jul 15; 17(3):121-8. PubMed ID: 18436152
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke.
    Miedema I, Uyttenboogaart M, Koopman K, De Keyser J, Luijckx GJ.
    Cerebrovasc Dis; 2010 Feb 15; 29(3):263-7. PubMed ID: 20090317
    [Abstract] [Full Text] [Related]

  • 9. Recanalization of middle cerebral artery and intracranial aneurysm in the same ischemic territory with intravenous administration of recombinant tissue plasminogen activator: case report.
    Matsuzaki T, Yoshino A, Sakatani K, Katayama Y.
    J Stroke Cerebrovasc Dis; 2011 Feb 15; 20(3):269-72. PubMed ID: 20630773
    [Abstract] [Full Text] [Related]

  • 10. Dosing errors did not have a major impact on outcome in the NINDS t-PA stroke study.
    Messé SR, Kasner SE, Cucchiara BL, Demchuk A, Tanne D, Ouyang B, Levine SR, NINDS t-PA Stroke Study Group.
    J Stroke Cerebrovasc Dis; 2011 Feb 15; 20(3):236-40. PubMed ID: 20656508
    [Abstract] [Full Text] [Related]

  • 11. Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke.
    Kimura K, Iguchi Y, Yamashita S, Shibazaki K, Kobayashi K, Inoue T.
    J Neurol Sci; 2008 Apr 15; 267(1-2):57-61. PubMed ID: 17964602
    [Abstract] [Full Text] [Related]

  • 12. Blood pressure variability after intravenous thrombolysis in acute stroke does not predict intracerebral hemorrhage but poor outcome.
    Kellert L, Sykora M, Gumbinger C, Herrmann O, Ringleb PA.
    Cerebrovasc Dis; 2012 Apr 15; 33(2):135-40. PubMed ID: 22179586
    [Abstract] [Full Text] [Related]

  • 13. Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorrhage after intravenous thrombolysis.
    Bravo Y, Martí-Fàbregas J, Cocho D, Rodríguez-Yáñez M, Castellanos M, de la Ossa NP, Roquer J, Obach V, Maestre J, Martí-Vilalta JL.
    Cerebrovasc Dis; 2008 Apr 15; 26(2):126-33. PubMed ID: 18560215
    [Abstract] [Full Text] [Related]

  • 14. The association of periprocedural hypertension and adverse outcomes in patients undergoing catheter-directed thrombolysis.
    Agle SC, McNally MM, Powell CS, Bogey WM, Parker FM, Stoner MC.
    Ann Vasc Surg; 2010 Jul 15; 24(5):609-14. PubMed ID: 20413257
    [Abstract] [Full Text] [Related]

  • 15. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusion<or=3 h and 3-6 h.
    Li YH, Li MH, Zhao ZG, Bai QK.
    Neurol India; 2009 Jul 15; 57(4):426-33. PubMed ID: 19770543
    [Abstract] [Full Text] [Related]

  • 16. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.
    Masrur S, Abdullah AR, Smith EE, Hidalgo R, El-Ghandour A, Rordorf G, Schwamm LH.
    J Stroke Cerebrovasc Dis; 2011 Jul 15; 20(2):124-30. PubMed ID: 20598579
    [Abstract] [Full Text] [Related]

  • 17. Hemorrhagic transformation of ischemic brain tissue after t-PA thrombolysis as detected by MRI may be asymptomatic, but impair neurological recovery.
    Kimura K, Iguchi Y, Shibazaki K, Aoki J, Terasawa Y.
    J Neurol Sci; 2008 Sep 15; 272(1-2):136-42. PubMed ID: 18602647
    [Abstract] [Full Text] [Related]

  • 18. Lower concentrations of thrombin-antithrombin complex (TAT) correlate to higher recanalisation rates among ischaemic stroke patients treated with t-PA.
    Fernandez-Cadenas I, Mendioroz M, Munuera J, Alvarez-Sabin J, Rovira A, Quiroga A, Corbeto N, Rubiera M, Delgado P, Rosell A, Ribó M, Molina CA, Montaner J.
    Thromb Haemost; 2009 Oct 15; 102(4):759-64. PubMed ID: 19806263
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.